Research Tools

Cell Guidance Systems Ltd

Brief Description

Cell Guidance Systems is based in Cambridge (UK), at the heart of one of the world's most exciting biotech regions. The company develops therapeutic products as well as medical research tools and technologies that expand the possibilities of life science research and medicine. The company's success has been achieved by working closely with many researchers from around the world (including Japan, USA, Netherlands, Italy, Singapore, and the UK) to develop truly innovative products that address unmet medical and research needs. Many of the Cell...

BioChoric

Brief Description

Biochoric uses isochoric supercooling to enable stable preservation of sensitive biological matter at sub-zero temperatures without freezing or solidification.

Inventors

Matthew Powell-Palm, Boris Rubinsky

Company Founders

Matthew Powell-Palm, UC Berkeley Professor Boris Rubinsky

Timeline 2021. Company founded

BioAmp Diagnostics

Brief Description

BioAmp develops novel, instrument-free screening and diagnostic tools to identify antibiotic-resistant bacteria in patient samples.

Inventors

Tara DeBoer, Niren Murthy, Jessica Marie Palomino, Lee Woodland Riley

Company Founders

Tara DeBoer

Timeline 2017. Company founded, and participated in the Citris Foundry accelerator program

Berkeley Yeast

Brief Description

Berkeley Yeast is a startup founded by UC Berkeley scientists, with grant funding from NSF, NIH, and USDA, as well as from venture capital. Berkeley Yeast bioengineers yeast strains that improve fermentation for brewers, winemakers, and beyond. The company uses synthetic biology to develop yeast strains with a variety of benefits, ranging from unprecedented control over flavors, to protection against the increasing vulnerability of crops, to greater product shelf stability and increased production efficiency. CEO Charles Denby co-founded the company based on the...

Artris Therapeutics, Inc.

Brief Description

Artris Therapeutics was founded to identify and develop cancer therapeutics. The company was co-founded by UC Berkeley Professor of Chemical Biology and Molecular Therapeutics Daniel Nomura.

Inventors

Leslie Bateman, Jessica Cestellos Spradlin, Tucker Huffman, David Miyamoto, Elizabeth Anne Moore, Truc Bang Nguyen, Daniel Nomura, James Arthur Olzmann, Allison Marie Roberts, Carl Ward

Timeline 2017. Company founded

Addition Therapeutics

Brief Description

Addition Therapeutics is transforming genetic medicine by developing RNA-only therapeutics that PRINT™ any genetic element at specific safe harbor sites.

Inventors

Kathy Collins, Jeremy John McIntyre, Sarah Madeline Palm, Heather Upton, Briana Nicole Van Treeck. Xiaozhu Zhang

Company Founders

UC Berkeley Professor Kathleen Collins

Timeline 2021. Company founded

Magnetic Tides

Brief Description

Magnetic Tides has developed a new non-invasive brain stimulation (NIBS) system capable of modulating brain function more reliably and effectively than previously existing NIBS methods.

NIBS is used as a research tool to safely, transiently alter the excitability state of targeted neurons when testing causal hypotheses about brain-behavior relationships. In addition, clinicians have recognized the potential of NIBS as a new intervention in the treatment of neurological and psychiatric disorders.

Inventors

Richard Ivry, Ludovica Labruna, Benjamin Inglis,...

Apertor Pharmaceuticals

Brief Description

Apertor creates novel molecular glues for therapeutic applications in multiple disease areas. The company applies a world-class synthetic biology platform using non-model organisms, a deep knowledge of complex natural products relevant to human health, and a computational pipeline enabled by structure-guided design. The result is a first-in-class approach to solving important pharmacological problems and delivering new, high-value treatment options for patients. The company was co-founded by UC Berkeley Professor of Chemical & Biomolecular Engineering and of...

Ansa Biotechnologies

Brief Description

With synthetic DNA fueling innovation in biological research, therapeutics, diagnostics, and biomanufacturing, there is an urgent need for faster and more accurate DNA synthesis. Currently, DNA is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a faster, more accurate, and cleaner enzyme-based DNA synthesis technology. The technique promises to dramatically accelerate innovation in biological research and engineering.

The approach is based on polymerase-...

Acrigen Biosciences, Inc.

Brief Description

Acrigin Biosciences is developing Precision Gene Editing Systems to harness the power of CRISPR for use in human therapeutics. Acrigen’s proprietary technology leverages novel αCas and μCas CRISPR gene editors coupled with ErAcrs (engineered anti-CRISPR proteins) to create an editing toolbox with best-in-class efficiency and precision. The company's technology will expand the impact of CRISPR by improving the efficacy and safety of novel gene editing therapies.

Inventors

Jennifer Doudna, Christof Fellmann, Haridha Shivram, Kyle Watters

Company Founders

David...